Pneumonia due to Methicillin resistant Staphylococcus aureus
ICD-10 J15.212 is a billable code used to indicate a diagnosis of pneumonia due to methicillin resistant staphylococcus aureus.
Pneumonia due to Methicillin-resistant Staphylococcus aureus (MRSA) is a serious lung infection caused by a strain of Staphylococcus aureus that is resistant to methicillin and other beta-lactam antibiotics. Clinically, patients may present with symptoms such as fever, cough, dyspnea, and chest pain. The infection primarily affects the lungs, leading to inflammation and consolidation of lung tissue, which can impair gas exchange. Disease progression can vary, with some patients experiencing rapid deterioration, particularly those with underlying health conditions or weakened immune systems. Diagnostic considerations include obtaining sputum cultures, blood cultures, and imaging studies such as chest X-rays or CT scans to confirm the presence of pneumonia and identify the causative organism. Early identification and appropriate antibiotic therapy are crucial for improving patient outcomes and reducing morbidity associated with this condition.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J15.212 specifically covers pneumonia caused by Methicillin-resistant Staphylococcus aureus (MRSA). This includes cases where MRSA is confirmed through culture or other diagnostic methods, and the pneumonia is clinically significant.
J15.212 should be used when the pneumonia is specifically due to MRSA, as opposed to other bacterial or viral causes. It is important to differentiate this code from J15.211 (Pneumonia due to Staphylococcus aureus) when MRSA is confirmed.
Documentation should include clinical findings, laboratory results confirming MRSA, imaging studies showing pneumonia, and treatment plans. Clear notes on the patient's history and response to treatment are also essential.
